Portfolio company
Seed, 2024
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops a single-molecule DNA sequencing platform for clinical diagnostics, agriculture, and biosecurity sectors.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Genetic Sequencing
This company develops nanopore-based technology for DNA sequencing to support researchers and clinicians in medical diagnostics and genomic analysis.
Geneseque
This company develops a single-molecule DNA sequencing technology for the life sciences sector and research partners.
Portal Biotech
The company develops nanopore-based instruments for single-molecule protein sequencing to serve researchers in drug discovery, diagnostics and biosecurity sectors.
ALIGNED BIO
This company develops nanowire-based biosensor platforms for single-molecule detection within the medical diagnostics and DNA sequencing markets.
Single molecule diagnostics
This company develops prenatal screening and oncology liquid biopsy tests for clinicians to identify genetic risks and monitor cancer treatments in patients.
3X Genetics
This company develops long-read genetic testing technology and diagnostics for biopharma companies to identify patients with rare repeat expansion disorders.
Singular Bio
The company develops single molecule detection technology for cell-free DNA analysis to provide non-invasive prenatal screening for the healthcare and genomics sectors.
Ultima Genomics
This company develops and manufactures high-throughput DNA sequencing platforms for researchers and clinicians performing population-scale genomic analysis.